Reshape, a Copenhagen, Denmark–primarily based AI and robotics-powered imaging and evaluation platform supplier, raised $20m in Sequence A funding.
The spherical was led by Astanor Ventures, R7, ACME, Y Combinator, Unity Co-Founder Nicholas Francis, and 21stBio.
The corporate intends to make use of the funds to increase its US operations and proceed automating R&D for agricultural, industrial, and biotech organizations.
Based in 2018 and led by Carl-Emil Grøn, CEO, Daniel Storgaard, and Magnus Nyborg Madsen, Reshape allows organic researchers to automate visible experiments by capturing and analyzing information factors immediately and precisely. The answer empowers analysis labs to speed up the tempo in the direction of scientific discoveries by minimizing errors and maximizing time for value-adding duties, guiding microbiological analysis with precision in the direction of a deeper understanding of nature. The corporate’s know-how is already utilized by dozens of main organizations together with Syngenta, College of Oxford, Novozymes, and others who save greater than 500,000 hours annually in handbook analysis processes.
FinSMEs
09/04/2024
